A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy

Original Article

M. Mathur, J. Barratt, B. Chacko, T.M. Chan, L. Kooienga, K.-H. Oh, M. Sahay, Y. Suzuki, M.G. Wong, J. Yarbrough, J. Xia, and B.J. Pereira

N Engl J Med 2024;390:20-31

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Course opens: 
01/03/2024
Course expires: 
01/04/2026

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Please sign in or create an account to take the course.